DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 149 filers reported holding DENALI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,358,904 | -7.6% | 58,523 | -18.3% | 0.01% | -22.2% |
| Q1 2024 | $1,470,279 | +69.6% | 71,651 | +70.5% | 0.01% | 0.0% |
| Q3 2023 | $866,873 | +67890.0% | 42,020 | -24.1% | 0.01% | -55.0% |
| Q1 2023 | $1,275 | -8.2% | 55,346 | +10.8% | 0.02% | -25.9% |
| Q4 2022 | $1,389 | -99.7% | 49,931 | +203.3% | 0.03% | +107.7% |
| Q2 2022 | $485,000 | -78.3% | 16,464 | -57.9% | 0.01% | -71.1% |
| Q1 2021 | $2,233,000 | +143.5% | 39,106 | +3.1% | 0.04% | 0.0% |
| Q2 2020 | $917,000 | – | 37,926 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
| Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
| Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
| Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
| MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
| Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
| PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
| WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |